Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
- Citation:
- Ayoub, B. M., S. Mowaka, M. M. Safar, N. Ashoush, M. G. Arafa, H. E. Michel, M. M. Tadros, M. M. Elmazar, and S. A. Mousa, "Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent", Sci Rep, vol. 8, issue 1, pp. 8959-8972, 2018.